Kadish A, Schaechter A, Subacius H, Thattassery E, Sanders W, Anderson KP, Dyer A, Goldberger J, Levine J. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2477–82....
ICD electrogramsinferolateral substratenonischemic cardiomyopathyIntroduction The majority of patients with nonischemic cardiomyopathy (NICM) present a perivalvular substrate that is either predominantly antero‐septal (AS) or infero‐lateral (IL), corresponding to specific ventricular tachycardia (VT) ...
Journal of cardiovascular electrophysiologyLuni FK, Singh H, Khan AR, et al. Mortality effect of ICD in primary prevention of nonischemic cardiomyopathy: a meta-analysis of ran- domized controlled trials. J Cardiovasc Electrophysiol. 2017;28:538- 43....
The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial. J Cardiovasc Electrophysiol 2015;26:424-33.Sedlacek K, Ruwald AC, Kutyifa V, McNitt S, Thomsen PE, Klein H, Stockburger M, Wichterle D, Merkely B,...
The wearable cardioverter defibrillator (WCD) is often used in patients at risk of sudden cardiac death (SCD) who are not yet candidates for an implantable cardioverter defibrillator (ICD). Newly diagnosed cardiomyopathy may be reversible, and a WCD may protect patients during the initial period ...
(sex = 1: men; sex = 2: women; IHD = 0: nonischemic cardiomyopathy; IHD = 1: ischemic cardiomyopathy). Figure 3. The life-table survival curves of women and men with chronic heart failure, mildly reduced ejection fraction, and nonischemic and ischemic cardiomyopathies. (sex = 1: ...